|
|
|
|
| LEADER |
01756nam a22003015i 4500 |
| 001 |
978-1-4020-2323-1 |
| 005 |
20191021152358.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2004 ne | s |||| 0|eng d |
| 020 |
|
|
|a 9781402023231
|
| 024 |
7 |
|
|a 10.1007/1-4020-2323-5
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Proteomics: Biomedical and Pharmaceutical Applications
|c edited by Hubert Hondermarck.
|
| 250 |
|
|
|a 1st ed. 2004.
|
| 260 |
# |
# |
|a Dordrecht :
|b Springer Netherlands :
|b Imprint: Springer,
|c 2004.
|
| 300 |
|
|
|a XII, 396 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Proteomics Today, Proteomics Tomorrow -- Proteomic Technologies and Application to the Study of Heart Disease -- Proteomics: Haematological Perspectives -- Proteomics in the Neurosciences -- Ocular Proteomics -- Proteomics in Oncology: the Breast Cancer Experience -- Proteomics of Hepatocellular Carcinoma: Present Status and Future Prospects -- Proteomics and Peptidomics of Gestational Disease -- Applications of Proteomics Technologies for Drug Discovery -- Proteomics and Adverse Drug Reactions -- Proteomics for Development of Immunotherapies -- Role of Proteomics in Medical Microbiology -- The Immunoproteome of H. pylori -- Proteomics of HIV-1 Virion -- Proteomics to Explore Pathogenesis and Drug Resistance Mechanisms in Protozoan Parasites.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Proteomics.
|
| 650 |
1 |
4 |
|a Biomedicine, general.
|
| 650 |
2 |
4 |
|a Proteomics.
|
| 700 |
1 |
|
|a Hondermarck, Hubert.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/1-4020-2323-5
|